Filter
1164
Text search:
drug
resistance
management
program
Featured
126
384
Language
Document type
696
170
159
55
41
25
7
7
2
1
1
Countries / Regions
68
48
47
34
33
30
30
30
27
26
25
24
23
22
21
20
19
17
16
14
13
13
12
11
10
9
8
8
7
7
7
7
6
6
6
6
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
562
73
54
29
27
16
15
Toolboxes
179
127
108
52
37
32
31
21
21
17
17
12
10
9
9
7
6
6
4
4
4
3
3
1
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In this edition, new information includes updated mask re
...
Government of Nepal has an obligation to ensure availability of affordable and high quality basic health care services to its population
The Best Buys for Disease Elimination is a practical, evidence-based guide to the most effective actions for countries to implement in order to eliminate communicable diseases. The guide highlights the efficient use of resources and prioritizing populations in vulnerable situations.
“The Region
...
This comprehensive analysis outlines the recommended mental health services in HIV
care, delivery modalities, required resources, guideline integration, special population
considerations, and implementation strategies with real-world examples
Results and Lessons Learned from CapacityPlus 2009-2015
Essential triple EMTCT services include testing for HIV, syphilis and HBV in ante-
natal care (ANC) settings; prompt and efficacious interventions to treat women
who test positive; prevent transmission of any of the infections to their children;
counseling for women and their partners to reduce t
...
TB in India 2017
recommended
Revised National TB Control Programme. Annual Status Report
Operational Guideline
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
